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Background: People with chronic psychosis often display theory of mind impairments that are not fully accounted
for by other, more general neurocognitive deficits. In these patients, both theory of mind and neurocognitive
deficits contribute to poor functioning, independently of psychotic symptoms. In young people with recent-onset
psychosis, however, it is unclear the extent to which theory of mind impairment is independent of neurocognitive
deficits. The primary aim of this study was to examine the evidence for specific theory of mind impairments in
early psychosis. A secondary aim was to explore the relations between theory of mind, neurocognition, symptom
severity, and functional outcomes.
Methods: Twenty-three patients who were within two years of their first psychotic episode and 19 healthy controls
completed theory of mind and neurocognitive batteries. Social functioning, quality of life, and symptom severity
were also assessed in patients.
Results: Patients demonstrated deficits in tasks assessing theory of mind and neurocognition relative to controls.
Patients’ deficits in theory of mind were evident even after adjusting for their deficits in neurocognition. Neither
theory of mind nor neurocognition predicted social functioning or quality of life in this early psychosis sample.
Severity of negative symptoms, however, was a significant predictor of both outcomes.
Conclusions: While a specific theory of mind impairment was evident in this early psychosis sample, severity of
negative symptoms emerged as the best predictor of poor functional outcome. Further early psychosis research is
needed to examine the longitudinal progression of theory of mind impairments – independent of neurocognitive
deficits – and their impact on psychosocial function.
Keywords: Early psychosis, First episode psychosis, Neurocognition, Occupational functioning, Quality of life,
Schizophrenia, Social functioning, Theory of mindBackground
Psychosis is usually associated with poor functioning.
Patients with psychosis, for example, typically display
poor social skills, report fewer relationships, and are
evaluated more negatively in social situations than
patients without psychosis [1-3]. As a result of this poor
functioning, patients with psychosis experience a range
of negative outcomes, including dissatisfaction with their
quality of life, unemployment, and depression [1-3].
Many interventions for psychosis, therefore, focus on
improving social skills and functional outcomes [4,5].* Correspondence: michael.connors@mq.edu.au
1ARC Centre of Excellence in Cognition and its Disorders, and Department of
Cognitive Science, Macquarie University, Sydney, NSW, Australia
Full list of author information is available at the end of the article
© 2014 Langdon et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Poor functioning in psychosis may be due, in part, to a
specific impairment in “theory of mind” (ToM) – the
ability to ascribe mental states to others so as to predict
and explain behaviour. ToM is essential to negotiating
social interactions and there is strong evidence that pa-
tients across all stages of psychosis, including those with
at-risk mental states, have impairment in this ability
[6,7]. Indeed, social cognitive deficits, including ToM,
appear to be stable over time in patients with early
psychosis [8] and across patients at different stages of
psychosis [7]. The poor functioning that is associated
with psychosis, however, may also be due, in part, to the
psychotic symptoms themselves or to other neurocog-
nitive deficits. Patients with psychosis typically display
deficits in attention, working memory, and many otheral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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functioning, independent of severity of negative symp-
toms [9-11].
While ToM and neurocognitive deficits appear to be
present at all stages of psychosis and contribute to poor
functioning, the ToM deficits – at least in chronic
patients – are not fully accounted for by the other, more
general neurocognitive deficits [12]. In addition, the
negative effects of ToM impairment on functioning in
chronic psychosis are present even when severity of
other neurocognitive deficits and negative symptoms are
taken into account [10]. Less is known, however, about
these relations at earlier stages of psychosis. Indeed,
Bora and Pantelis [6] argue that the extent to which
ToM deficits are reducible to other neurocognitive defi-
cits at earlier stages of psychosis is unclear. It is possible,
for example, that the deterioration of selective theory
of mind capacity and neurocognitive functioning follow
different trajectories in psychosis.
To address these issues, Sullivan et al. [13] recently
examined the relations between ToM, general cognition,
symptoms and social functioning in a sample of patients
in their first psychotic episode. Sullivan et al. found that
social functioning in their sample was associated with
ToM (as measured by the Hinting task) and verbal IQ,
but not with other general cognitive measures or a mea-
sure of negative symptoms that excluded symptoms that
overlapped with poor social functioning (e.g. asociality).
These findings suggest that both theory of mind and
aspects of neurocognition contribute to poor social
functioning in early psychosis. However, later follow-ups
found that these variables did not predict functional out-
comes at six months or one year [14]. These important
studies also had some limitations. The approach of
excluding some negative symptoms, for example, is
potentially problematic since no evidence was provided
to support the categorisation of a negative symptom as
social or not. In addition, Sullivan and colleagues used
a rather limited neuropsychological battery. ToM was
assessed with the Hinting task, for instance, which may
produce skewed data that limits the analyses that can be
performed. Similarly, neurocognition was assessed using
only three brief measures. Given these limitations and
the ambiguous findings to date, the current study sought
to extend Sullivan et al.’s research using a more detailed
neuropsychological battery.
Current study
As the relations between ToM and neurocognition at
early stages of psychosis have important implications for
clinical interventions, we aimed to more comprehen-
sively assess neurocognition and ToM in a first episode
psychosis sample. Our primary aim was to examine
theory of mind performance in early psychosis and itsrelative independence from neurocognition. Following
previous research with patients with chronic psychosis
[10], our secondary aim was to explore the relations bet-
ween theory of mind, neurocognition, symptom severity,
and functioning in an early psychosis sample. Patients,
who were within the first two years of their first psy-
chotic episode, and healthy controls completed batteries
of ToM and neurocognition. The social functioning,
quality of life, and symptom severity of patients were
also assessed. If ToM was selectively impaired, as it is in
people with chronic psychotic symptoms, we expected
that patients and controls would show differences in this
ability independent of any differences in neurocognition.
Methods
Participants
Twenty-three patients were recruited from two early
psychosis intervention programs in New South Wales,
Australia. All patients were in the first two years of their
first treatment by mental health services. Patients were
interviewed using the Diagnostic Interview for Psychosis
[15] to confirm diagnosis according to ICD-10 criteria
[16]. Seventeen of these patients had a diagnosis of
“Paranoid Schizophrenia,” 4 had a diagnosis of “Undif-
ferentiated Schizophrenia,” 1 had a diagnosis of “Schizoaf-
fective Disorder – Bipolar Subtype,” and 1 had a diagnosis
of “Other Non-Organic Psychotic Disorder.” Patients with
organic brain disorders or a comorbid diagnosis of sub-
stance dependence according to the treating clinician
were excluded. All the patients were prescribed low dose
atypical neuroleptics but several disclosed their non-
compliance, making it unreliable to explore medication
effects. Consistent with the gender imbalance in young
cohorts with a schizophrenia-like psychosis [17], 22 of the
patients were male and one patient was female.
Nineteen healthy controls (17 male, 2 female) were
recruited from the general community to match the pa-
tient group on age, gender distribution, and formal edu-
cation. The controls were screened using the affective,
psychotic, and substance abuse screening modules from
the Structured Clinical Interview for DSM-IV Axis 1
Disorders [18]. In accord with research in this area,
exclusion criteria for both groups included organic brain
disorders and substance dependence (screened as above).
All participants were English-speaking and gave written
informed consent. Demographic features of both groups
and clinical features of patients are summarised in
Table 1.
The study followed the World Medical Association
Declaration of Helsinki – Ethical Principles for Medical
Research Involving Human Subjects, and was approved by
the Hunter Area Research Ethics Committee (reference
number 01/12/12/3.23), South Western Sydney Area
Health Service Research Ethics Committee (reference
Table 1 Demographics of patients and controls
Patients Healthy controls Significance test
Males:females 22:1 17:2 χ2(1) = .599
Age (years) 20.91 ± 1.83 (18-25) 20.79 ± 1.81 (17-24) t(40) = .219
Education (years) 11.43 ± 2.02 (8-18) 12.82 ± 1.94 (9-16) t(40) = 2.247*
IQ 96.65 ± 8.41 103.42 ± 9.32 t(40) = 2.472*
Age of illness onset (years) 19.91 ± 1.95 (16-24)
Duration of illness (weeks) 50.74 ± 29.50 (12-104)
SAPS Positive Symptoms 1.25 ± .94 (0.00-3.75)
SANS Negative Symptoms 2.18 ± .72 (0.60-3.80)
Social Functioning 50.87 ± 12.12 (30-80)
Quality of Life 58.22 ± 22.78 (20-120)
Note. Data expressed as means ± SD (range in parentheses). *p < .05. Positive and negative symptoms assessed using the Scales for the Assessment of Positive and
Negative Symptoms of Schizophrenia (SAPS and SANS: Andreasen, 1983, 1984). The overall Positive and Negative rating is the average of global ratings on the
SAPS and SANS respectively (‘0’ = absent; ‘1’ = questionable; ‘2’ =mild; ‘3’ =moderate; ‘4’ =marked; ‘5’ = severe).
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Ethics Committee (reference number 00/10/03).
Materials and procedure
Theory of Mind (ToM)
The first ToM measure was a non-verbal picture-
sequencing task [19-21]. Participants were shown four
picture-cards in a fixed, incorrect order. Participants were
asked to reorder the picture-cards to provide a logical
sequence of events. There were four types of sequences
(four sequences per type): ToM “false belief stories” that
required participants to go beyond the immediate ob-
jective information to infer a character’s mistaken belief;
“social-script stories” that controlled for simple social rea-
soning; “mechanical stories” that controlled for physical
cause-and-effect reasoning; and “capture stories” that con-
trolled for inhibition of an obvious but misleading cue.
Each sequence scored two points if the first card was posi-
tioned correctly, two points if the last card was positioned
correctly, and one point each if the second and third cards
were positioned correctly. Scores were averaged across
each type of story (range 0–6).
The second ToM measure was a joke appreciation task
[20-22]. Participants were shown a series of visual car-
toons and asked to explain the humour. There were 11
“ToM” cartoons in which the joke depended on under-
standing a character’s false belief or mental state, and 11
“control” cartoons in which the joke did not depend on
inferring mental states but instead involved situational
anomalies. Responses were scored from 0 (an incorrect
or irrelevant answer) to 3 (a complete, correct expla-
nation). Scores were averaged across the two types of
cartoon.
The third ToM measure was a story comprehension
task [20-22]. Participants were asked to read a series of
stories and answer a question about each. There wereeight “ToM” stories that involved understanding the
mental states of the characters and eight control stories
that required only general comprehension. The length of
the stories and the complexities of the sentences were
matched across the two types of story. Responses were
scored from 0 (an incorrect answer) to 2 (a complete,
correct answer). Scores were averaged across the two
types of story.
Neurocognition
Participants also completed a battery of neurocognition
tests. IQ was estimated using the National Adult Reading
Test [23]. Visual memory was assessed using the visual
memory span test from the Wechsler Adult Intelligence
Scale-Revised [24]. Verbal memory was assessed using the
logical memories subtest from the WAIS [24]. Planning
was assessed using the number of planning moves on a
computerised Tower of London task [25]. Set shifting was
assessed using the number of categories achieved on
the Wisconsin Card Sort Test [26]. Verbal fluency was
assessed using the Controlled Oral Word Association Test
[27]. Semantic fluency was assessed by asking participants
to generate the names of as many exemplars of a category
(in this study; food, animals, and furniture) that they could
think of in 60 seconds. Inhibition was indexed by time
taken on the colour-word interference condition that
followed the colour-naming and colour-word reading
conditions of a bespoke Stroop task [28].
Clinical interviews
The scales for Assessment of Positive and Negative Symp-
toms of Schizophrenia [29,30] were used to rate symptom
severity in patients. The social and global functioning of
patients were also assessed using the Social and Occupa-
tional Functioning Assessment Scale [31] and the Quality
of Life Scale [32].
Table 2 Differences between patients and controls in ToM and neurocognition
Patients Healthy controls Significance test: t(40)
ToM −1.60 ± 2.16 1.94 ± 1.04 6.55**
Picture sequencing 4.80 ± 1.19 5.87 ± .28 3.81**
Joke appreciation 1.26 ± .47 1.90 ± .27 5.23**
Story comprehension .72 ± .31 1.19 ± .27 5.17**
Neurocognition −3.66 ± 3.77 4.21 ± 3.89 6.57**
IQ 96.65 ± 8.41 103.42 ± 9.32 2.47*
Visual memory 16.78 ± 3.26 19.84 ± 2.73 3.25**
Verbal memory 26.39 ± 15.76 54.21 ± 13.44 6.08**
Verbal fluency 28.00 ± 9.29 44.58 ± 13.47 4.71**
Semantic fluency 32.43 ± 9.45 56.95 ± 12.94 7.09**
Inhibition 32.30 ± 9.88 23.24 ± 5.92 3.49**
Set-Shifting -.17 ± .93 .20 ± .50 1.54
Planning 60.26 ± 7.84 55.63 ± 6.79 2.02
Note. Data expressed as means ± SD. *p < .05, **p < .01.
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The correlations between scores from the three ToM tasks
were examined first to assess convergent validity. To ob-
tain a global index of ToM abilities, scores from the three
ToM measures were then converted to z-scores and aver-
aged to produce a single composite ToM score.
ToM and neurocognition scores of the patients and
controls were compared using independent samples t-
tests. ToM and neurocognitive score differences between
patients and controls were converted to effect sizes in
terms of Cohen’s d. In order to further reduce the data
for subsequent analyses, a composite neurocognition
score was also calculated by converting scores from the
individual measures into z-scores across groups, scaled
such that higher scores indicated better function, and















Figure 1 Patients’ deficits in ToM and different neurocognitive domascore. An ANCOVA was then used to compare ToM
between groups, adjusting for the composite score of
neurocognition.
To explore the relations between ToM, neurocog-
nition, symptom severity, and functioning, zero-order
correlations were assessed between these measures in
patients. To examine predictors of functioning, hierar-
chical regression analyses were conducted with social
functioning and quality of life as the dependent varia-
bles, and neurocognition, ToM and severity of negative
symptoms entered as the predictors.
Results
Relationships between ToM measures
All three measures of ToM correlated with each other.
The picture sequencing ToM score correlated with ToMins relative to controls.
Table 3 Zero-order correlations between ToM, neurocognition, symptom severity, and social functioning in patients
ToM Neurocognition Negative symptoms Positive symptoms Quality of life Social functioning
ToM .70** -.50* -.01 .26 .16
Neurocognition .70** -.47* −.06 .53* .30
Negative symptoms -.50* -.47* .18 -.50* -.51*
Positive symptoms -.01 -.06 .18 .02 -.09
Quality of Life .26 .53* -.50* .02 .85**
Social Functioning .16 .30 -.51* -.09 .85**
Note. *p < .05, **p < .01.
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p < .01, and the story comprehension task, r(42) = .47,
p < .01. The latter two measures also correlated signifi-
cantly, r(42) = .59, p < .01.Table 4 Summary of hierarchical regression analyses
predicting social functioning and quality of life in early
psychosis patients
ß t p R2
Predicting SOFAS Scores of Social Functioning
Step 1 .09
Neurocognition .30 1.39 .18
Step 2 .09
Neurocognition .34 1.12 .28
ToM -.07 .21 .83
Step 3 .30Specificity of ToM deficits in patients
Patients performed worse than controls in ToM tasks
and in all measures of neurocognition. These differences,
however, did not reach statistical significance for set
shifting and planning (see Table 2). Effect sizes are
shown in Figure 1. Patients showed particularly large im-
pairments in ToM, verbal memory, and semantic fluency
relative to controls. To determine whether ToM deficits
were evident when neurocognitive performance was
accounted for, we compared patients and controls’ com-
posite ToM scores using an ANCOVA with the compos-
ite score of neurocognition as a covariate. Patients still
displayed a significant deficit in ToM compared to con-
trols, F(1, 38) = 5.60, p = .02, ηp
2 = .13. There was also a
significant effect of neurocognition on ToM independent
of group, F(1, 38) = 25.81, p < .01, ηp
2 = .41. Levene’s test
indicated that the assumption of equality of error varian-
ces was met for this analysis, F(1, 39) = 3.83, p = .06.
Patients and controls did not differ on any of the control
conditions in the ToM tasks (all ps > .05).Neurocognition .20 .70 .49
ToM -.22 .76 .46
Negative symptoms -.53 2.30 .03*
Predicting QLS Scores of Life Satisfaction
Step 1 .29
Neurocognition .53 2.83 .01
Step 2 .29
Neurocognition .60 2.22 .04
ToM -.09 .33 .74
Step 3 .42
Neurocognition .48 1.89 .08
ToM -.21 .81 .43
Negative symptoms -.42 2.00 .06!
*p < .05; ! p < .10.ToM, neurocognition, symptom severity, and functioning
in patients
Correlations between ToM, neurocognition, symptom
severity, and functional outcomes are shown in Table 3.
Focusing on correlations with the latter, ToM did not
correlate significantly with either quality of life or the
SOFAS social functioning measure. Neurocognition was
significantly correlated with quality of life. This relation-
ship, however, was not significant in a partial correlation
that controlled for negative symptoms (rp = .70, p = .76).
Negative symptoms were associated with poorer social
functioning and quality of life, as well as lower ToM and
neurocognition. Positive symptoms were not signifi-
cantly correlated with any of the other domains assessed
(all ps > .42).Predictors of social functioning and quality of life
Since previous research indicates that neurocognitive
deficits contribute to theory of mind impairment which,
in turn, associates with negative symptoms (in accord
with our zero-order correlation results), we conducted
follow-up hierarchical regression analyses to examine
the cumulative effects of these measures when pre-
dicting patients’ social functioning and quality of life.
Table 4 summarises the results. While acknowledging
the need for caution given our small sample size and the
intercorrelations between predictors, findings indicate
that neither neurocognition, nor the combination of
neurocognition and ToM, predicted our functioning
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rity of negative symptoms was a significant predictor of
poor social functioning and showed a similar trend for
reduced quality of life, having adjusted for the effects of
neurocognition and ToM. Subsequent backward regres-
sion analyses reduced the full models in each case to leave
negative symptoms as the sole predictor, F(1,20) = 7.37,
p = .01 and F(2,19) = 6.25, p = .01 respectively.
Discussion
Consistent with previous research [6], patients in the
early stages of psychosis demonstrated deficits in both
ToM and neurocognition. Importantly, however, while
ToM deficits co-occurred with deficits in neurocogni-
tion – particularly deficits in verbal memory and seman-
tic fluency – they were not fully accounted for by these
neurocognitive deficits. This evidence for specificity of
ToM impairment at early stages of psychosis is consis-
tent with evidence elsewhere that ToM deficits may be a
trait marker of schizophrenia [6,25].
Nevertheless, neither ToM nor neurocognitive deficits
in the early psychosis patients predicted poor functional
outcomes. This is consistent with Sullivan et al.’s [14]
finding that ToM does not predict poor outcomes longi-
tudinally in the early stages of psychosis. The findings,
however, are in contrast to other cross-sectional research
which has found that ToM deficits are associated with
poor social functioning in both early [13] and chro-
nic psychosis [10]. These divergent findings may reflect
differences in methodology. The current study used dif-
ferent measures of ToM to those employed in Sullivan
et al.’s [13] cross-sectional study, which used the Hinting
task to test sensitivity to intended meanings of indirect
hints. It is possible that the Hinting task taps social
knowledge in addition to ToM and so better predicts
functional outcomes. Sullivan et al.’s [14] failure, how-
ever, to find an association longitudinally, together with
the current findings, suggests that other factors, inclu-
ding severity of negative symptoms, may play a greater
role in determining real-world functioning, at least in
the early stages of psychosis.
The current study was limited by its relatively small
sample size and the fact that it did not consider the
effects of general psychopathology and comorbid Axis-II
symptomatology. With regard to the latter, borderline
traits in adolescents are associated with ‘hyper-mentalis-
ing’ errors (i.e., errors of inferring mental states in others
without reasonable justification) [33], rather than the
‘hypo-mentalising’ errors (i.e., errors of failing to infer
mental states) seen in our early psychosis sample. In
addition, we could not examine medication effects and
relied on the SOFAS and QLS, which although widely-
used, are based on interview and provide only gross glo-
bal estimates of functioning. Future research could usemore sensitive and targeted measures of functioning,
including scales that require direct observation of actual
or role-played functioning, to assess different domains of
functional outcomes. Future research could also examine
whether subtypes of negative symptoms differentially
impact functioning [34].
In conclusion, patients in our early psychosis sample
displayed deficits in ToM, which were independent of
their neurocognitive deficits. Negative symptoms, and
not these cognitive deficits, were the strongest predictor
of poor functioning. This is in contrast with the evidence
that ToM deficits are the strongest predictors of social
dysfunction in patients living with chronic psychotic
symptoms [10]. In addition, the significant correlations
in our sample between negative symptoms and impaired
ToM and neurocognition indicate the challenges of
separating their effects on functioning. While our results
require replication with a larger, more gender-balanced
early psychosis sample, they reinforce the need for future
early psychosis research to examine the developmental
progression of ToM deficits and their real-world conse-
quences over time.
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